Replies to post #436821 on Amarin Corp Plc (AMRN)

[JRoon71]

PDude, on the surface, I see what you are saying. However, I think they came to the realization that it was going to take way too long, and be way too costly to completely build out Europe. They simply don't have the structure to do it.

So, they either sell the company, and/or Europe to a BP for a very small premium now, or they partner, get some nice chunks of cash, plus royalties, become profitable and cashflow positive immediately, and turn their entire focus to the new formulation and taking back the U.S. market.

Don't forget, Europe is now immediately a profit center, as opposed to yesterday, when it was going to be a cash drain for years to come.

We also don't know what their ultimate goal is, or what Europe may mean in the future.

[mrmainstreet]

Well the alternative was trying to cover 59 countries as a small company, so if it's not a buyout this is the next best thing IMO. Especially if they plan to refocus on the US market.

I know you're a big proponent of Vascepa, so what are your thoughts on a new potential new indication via the latest patents? Something that excludes generics.

[rosemountbomber]

I guess the Netflix model didn't pan out.  Not even sure if they presented such an idea to the EU countries.  Some of those (if not most) applications for reimbursement were already submitted.  Good to see posts from you Mark

[hayward]

Pharmacydude

For someone that has sold his shares why do you care and continue to post ? Sour grapes ? I am sure the people that still own shares don't care what you think !

Michael